Q32 Bio (QTTB) Short term Debt (2023 - 2026)
Q32 Bio (QTTB) recorded quarterly Short term Debt of $6.2 million in Q1 2026, little changed quarter-over-quarter from $6.2 million in Q4 2025, and up 33.83% on a YoY basis from $4.7 million in Q1 2025.
Q32 Bio (QTTB) Short term Debt (2023 - 2026) Analysis & Trends
Q32 Bio's Short term Debt history runs 4 years deep, the most recent figure standing at $6.2 million for Q1 2026.
- In Q1 2026, Short term Debt rose 33.83% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $6.2 million (up 33.83% YoY), while the FY2025 annual figure was $6.2 million, up 101.32% from the prior year.
- Short term Debt was $6.2 million for Q1 2026 at Q32 Bio, roughly flat from $6.2 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $6.2 million in Q1 2026 to a low of $878000.0 in Q4 2023.
- Historically, Short term Debt has averaged $4.2 million across 4 years, with a median of $4.7 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Short term Debt surged 306.52% in 2025, then surged 33.83% in 2026.
- A 4-year view of Short term Debt shows it stood at $878000.0 in 2023, then jumped by 252.73% to $3.1 million in 2024, then jumped by 101.32% to $6.2 million in 2025, then advanced by 0.06% to $6.2 million in 2026.
- The last three Short term Debt figures came in at $6.2 million (Q1 2026), $6.2 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.24 Mn |
| Dec 31, 2025 | 6.24 Mn |
| Sep 30, 2025 | 6.23 Mn |
| Jun 30, 2025 | 6.23 Mn |
| Mar 31, 2025 | 4.66 Mn |
| Dec 31, 2024 | 3.10 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Dec 31, 2023 | 878,000.00 |